Label: TIM-BRIM-DOR-LAT- timolol - brimonidine - dorzolamide - latanoprost solution/ drops
-
Contains inactivated NDC Code(s)
NDC Code(s): 70261-522-05 - Packager: ImprimisRx NJ
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated May 8, 2018
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- STORAGE AND HANDLING
- Bottle Label
-
INGREDIENTS AND APPEARANCE
TIM-BRIM-DOR-LAT
timolol - brimonidine - dorzolamide - latanoprost solution/ dropsProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70261-522 Route of Administration OPHTHALMIC Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DORZOLAMIDE HYDROCHLORIDE (UNII: QZO5366EW7) (DORZOLAMIDE - UNII:9JDX055TW1) DORZOLAMIDE 20 mg in 1 mL BRIMONIDINE TARTRATE (UNII: 4S9CL2DY2H) (BRIMONIDINE - UNII:E6GNX3HHTE) BRIMONIDINE TARTRATE 1.5 mg in 1 mL LATANOPROST (UNII: 6Z5B6HVF6O) (LATANOPROST - UNII:6Z5B6HVF6O) LATANOPROST 0.05 mg in 1 mL TIMOLOL MALEATE (UNII: P8Y54F701R) (TIMOLOL ANHYDROUS - UNII:5JKY92S7BR) TIMOLOL ANHYDROUS 5 mg in 1 mL Product Characteristics Color Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:70261-522-05 5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product 01/01/2018 
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2018 Labeler - ImprimisRx NJ (931390178)
Bottle Label